IJPR-Iranian Journal of Pharmaceutical Research. 2016; 15 (1): 331-339
in English
| IMEMR
| ID: emr-177564
ABSTRACT
Objectives:
Graft versus host disease [GVHD] is a life threatening reaction in the stem cell transplantation process. Nowadays Cyclosporine is the most commonly utilized agent for GVHD prophylaxis and it has a major role in successful transplantation. Cyclosporine has been applied for many years in this field but it could be stated that currently no general consensus is available for its optimal method of administration. Conditions related to cyclosporine administration and possible related adverse reactions observed closely in our patients with the aim of constructing a comprehensive practice guideline in the future
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Transplantation, Homologous
/
Surveys and Questionnaires
/
Drug Utilization Review
/
Hematopoietic Stem Cell Transplantation
/
Transplant Recipients
/
Graft vs Host Disease
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
English
Journal:
Iran. J. Pharm. Res.
Year:
2016
Similar
MEDLINE
...
LILACS
LIS